BEVERLY HILLS, Calif, Dec. 21, 2020 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative th ...

TAMPA, Florida, Sept. 12, 2019 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative treatme ...

GT Biopharma, Inc. GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025. GTB-5550 TriKE ® IND submission for treatment of B7H3 positive solid tumors ...

MG has been tight-lipped about the technical specifications of its electric Cyberster drop-top, but engineers have shared one wild figure ahead of its official reveal this week ...

--GT Biopharma, Inc. an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager technology platform is pleased to announce the presentation of ...

--GT Biopharma, Inc., a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer cell engager, TriKE ® platform ...